Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment

Herken, H; Akyol, O; Yilmaz, HR; Tutkun, H; Savas, HA; Ozen, ME; Kalenderoglu, A; Gulec, M

doi:10.1002/hup.742

Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment

Copy For Citation

Herken H., Akyol O., Yilmaz H., Tutkun H., Savas H., Ozen M., ...More

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, vol.21, no.1, pp.53-59, 2006 (SCI-Expanded)

Publication Type: Article / Article
Volume: 21 Issue: 1
Publication Date: 2006
Doi Number: 10.1002/hup.742
Journal Name: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.53-59
Süleyman Demirel University Affiliated: No

Abstract

Objective In the present study, we aimed to investigate whether nitric oxide (NO) levels and activities of xanthine oxidase (XO), superoxide dismutase (SOD), and adenosine deaminase (ADA) are associated with Panic disorder (PD) as well as impact of psychopharmacological treatments on NO, SOD, ADA, and XO levels in PD.